RARE DISEASE WORKSHOP SERIES Improving the Clinical Development Process. Disclaimer:

Similar documents
PROMIS Overview: Development of New Tools for Measuring Health-related Quality of Life and Related Outcomes in Patients with Chronic Diseases

The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System

The Future of Measuring Patient-Reported Outcomes in Rheumatology

3/5/2014. New Research Initiatives to Improve QoL of Persons with SCI Across the Globe. What Are the SCI International Datasets?

Patient Reported Outcomes in Clinical Research. Overview 11/30/2015. Why measure patientreported

Measuring Patient Health with PROMIS : Applications for Social Integration Research and Care

SLEEP DISTURBANCE ABOUT SLEEP DISTURBANCE INTRODUCTION TO ASSESSMENT OPTIONS. 6/27/2018 PROMIS Sleep Disturbance Page 1

Instruments Available for Use in Assessment Center

For more information: Quality of Life. World Health Organization Definition of Health

Utilizing the NIH Patient-Reported Outcomes Measurement Information System

PAIN INTERFERENCE. ADULT ADULT CANCER PEDIATRIC PARENT PROXY PROMIS-Ca Bank v1.1 Pain Interference PROMIS-Ca Bank v1.0 Pain Interference*

Patient Reported Outcomes in Sickle Cell Disease. Marsha J. Treadwell, PhD 5 October 2016

FATIGUE. A brief guide to the PROMIS Fatigue instruments:

INTRODUCTION TO ASSESSMENT OPTIONS

ANXIETY A brief guide to the PROMIS Anxiety instruments:

MEANING AND PURPOSE. ADULT PEDIATRIC PARENT PROXY PROMIS Item Bank v1.0 Meaning and Purpose PROMIS Short Form v1.0 Meaning and Purpose 4a

Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements

PSYCHOLOGICAL STRESS EXPERIENCES

Patient Reported Outcomes in Arthritis, TJR, and Physical Activity Research

ANXIETY. A brief guide to the PROMIS Anxiety instruments:

Patient-Centered Endpoints in Oncology

GENERAL SELF-EFFICACY AND SELF-EFFICACY FOR MANAGING CHRONIC CONDITIONS

INTRODUCTION TO ASSESSMENT OPTIONS

Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS to ASCQ-Me

Ware NIH Lecture Handouts

PHYSICAL FUNCTION A brief guide to the PROMIS Physical Function instruments:

PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS SLEEP DISTURBANCE AND NEURO-QOL SLEEP DISTURBANCE

PHYSICAL STRESS EXPERIENCES

Journal of Clinical Epidemiology 63 (2010) 1179e1194

ABOUT PHYSICAL ACTIVITY

PROMIS ANXIETY AND KESSLER 6 MENTAL HEALTH SCALE PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES

PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES

Patient Reported Outcomes

10/30/2013. Disclosures. Defining Flares in RA RA Flare Group

Table of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix

PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS GLOBAL HEALTH-PHYSICAL AND VR-12- PHYSICAL

PROMIS PAIN INTERFERENCE AND BRIEF PAIN INVENTORY INTERFERENCE

COGNITIVE FUNCTION. PROMIS Pediatric Item Bank v1.0 Cognitive Function PROMIS Pediatric Short Form v1.0 Cognitive Function 7a

PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS PEDIATRIC ANXIETY AND NEURO-QOL PEDIATRIC ANXIETY

PROMIS DEPRESSION AND NEURO-QOL DEPRESSION

PROSETTA STONE METHODOLOGY A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES

Health-Related Quality of Life (HRQoL)

ABOUT SUBSTANCE USE INTRODUCTION TO ASSESSMENT OPTIONS SUBSTANCE USE. 2/26/2018 PROMIS Substance Use Page 1

Smoking Social Motivations

PROMIS DEPRESSION AND CES-D

PROMIS User Manual (Version 1.1)

PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES

Disclaimer. ISPOR 22 nd Annual International Meeting May 24, 2017 Boston, Massachusetts, USA

PROMIS ANXIETY AND MOOD AND ANXIETY SYMPTOM QUESTIONNAIRE PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES

GLOBAL HEALTH. PROMIS Pediatric Scale v1.0 Global Health 7 PROMIS Pediatric Scale v1.0 Global Health 7+2

Addressing Content Validity of PRO Measures: The Unique Case of Rare Diseases

Creating a Child Self-Report Measure of Adverse Events Related to Cancer Treatment; Providing a Voice for the Child

PROMIS Physical Function PROMIS Fatigue PROMIS Sleep-Related Impairment 3 Activities and Pain Impact Scale

Challenges and Opportunities for Using Common PRO Measures in Comparative Effectiveness Research

PROMIS: What is it, Why Use it, and How to Advance the Mission of Integrative Oncology

Guideline scope Persistent pain: assessment and management

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin

ABOUT SMOKING NEGATIVE PSYCHOSOCIAL EXPECTANCIES

Susan Zieman, M.D., Ph.D. Medical Officer, Geriatrics Branch Division of Geriatrics and Clinical Gerontology National Institute on Aging/National

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme

Quality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition

PATIENT REPORTED OUTCOMES

PROMIS Sexual Function and Satisfaction. Manual

A Review of Patient-Reported Outcome Labeling in the United States ( ) Joseph C. Cappelleri Pfizer Inc

The PhenX Toolkit: Standard Measures for Collaborative Research

The promise of PROMIS: Using item response theory to improve assessment of patient-reported outcomes

A Review of FDA PRO Labeling ( ) Ari Gnanasakthy RTI Health Solutions

Performance of PROMIS and Legacy Measures Among Advanced Breast Cancer Patients and Their Caregivers

Migrating a PRO Instrument. Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket)

DEPARTMENT <EXPERIMENTAL-CLINICAL AND HEALTH PSYCHOLOGY... > RESEARCH GROUP <.GHPLAB.. > PSYCHOLOGICAL EVALUATION. Geert Crombez

Overcoming Challenges in Outcome Measurement in Rare Diseases and Pediatric Populations

NIH Toolbox. Technical Manual

Richard C. Gershon, PhD.

Lessons from the Development of a Canadian National System of Surveillance

Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications

Electronic patient and parent reported outcomes in pediatric clinical practice Haverman, L.

RARE DISEASE WORKSHOP SERIES Improving the Clinical Development Process. Disclaimer:

Lessons learned along the path to qualification of an IBS outcome measure*

Two-item PROMIS global physical and mental health scales

Quality of Life Instrument Development in Adults. American Cochlear Implant Alliance /8/18

Purpose of Workshop. Faculty. Culturally Sensitive Research. ISOQOL Workshop 19 Oct 2005

Assessing Consumer Responses to RRP: Experience at PMI in Developing Fit-for-Purpose Self-Report Instruments

IN A RECENT AMERICAN Congress of Rehabilitation

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA

Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

SECOND ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP

Electronic Capture of PROs in NCI Clinical Trials

Measures of Self-Efficacy

Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance. Donald L. Patrick University of Washington

PANEL QUESTIONS FOR REGULATORY CONSIDERATION

Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Developing and Testing Survey Items

Additional resources from Lunch and Learn: The Good, Bad, and the Ugly: Treatment of Complex Regional Pain Syndrome in Pediatrics

Questionnaire Development and Testing. Barbara J. Stussman Survey Statistician NIH/NCCAM

Questionnaire Development and Testing. Acknowledgments. Outline of Lecture. Barbara J. Stussman Survey Statistician NIH/NCCAM

Integrated IAPT Data Guide

European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC

Sources of Comparability Between Probability Sample Estimates and Nonprobability Web Sample Estimates

Using Performance and Outcome Measures for Enhancing the Quality of Behavioral Health Care Services

Engaging with the new EU regulatory landscape for medical devices. Challenges and opportunities

Transcription:

RARE DISEASE WORKSHOP SERIES Improving the Clinical Development Process Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the Kakkis EveryLife Foundation, for educational purposes only. They are for use by drug development professionals and statisticians, and are not to be used to guide the prescribing or use of any of the drugs mentioned in the slides. To obtain information on a particular drug, refer to the drug labeling. Do not reproduce or distribute the slides (full set or any portion of) without the permission of the author.

KAKKIS Foundation Clinical Evaluation of Rare Disease Treatments June 14-15, 2011 Washington DC James Witter MD, PhD Chief Science Officer NIH/NIAMS www.nihpromis.org Dynamic Tools to Measure Health Outcomes from the Patient Perspective

The Tower of Babel (Brueghel, 1563)

Vision-Mission: Vision The Patient-Reported Outcomes Measurement Information System (PROMIS), funded by the National Institutes of Health, aims to provide clinicians and researchers access to efficient, precise, valid, Click and responsive to edit adult- Master and title child-reported style measures of health. Mission PROMIS uses measurement science to create an efficient state-of-the-art assessment system for selfreported health.

Overall Framework: Assessments Dimension Objectiveness Clinical Measure (Some Non-objective element Involved) Biomarker Who measures Patient Clinician Observer Instrument Relationship to Tangible Clinical Benefit Direct Indirect Direct Indirect Direct Indirect Indirect How obtained Naturalistic Artificial Procedure VAS for pain intensity; NONE Possible PANSS for schizophrenia symptoms NONE Possible Observation of seizures for epilepsy outcomes NONE Possible HbA1c for cardiovascular outcomes; endocrine stimulation tests for endocrine organ function) 2 nd Annual Critical Path Institute-PRO Consortium: FDA Workshop March 15, 2011 Silver Spring, MD

NIH Assessment Tools NIH Toolbox www.nihtoolbox.org/default.aspx Assessment of Neurological and Behavioral Function Neuro-QOL www.neuroqol.org/default.aspx Quality of Life in Neurological Disorders The EXAMINER http://examiner.ucsf.edu Neurobehavioral Evaluation and Research Phen-X www.phenx.org Consensus Measures for Phenotypes and Exposures PROMIS www.nihpromis.org Patient-Reported Outcomes Measurement Information System

Patient-Reported Outcomes (PROs) FDA and NIH recognize PROs as important outcomes to answer clinical questions translating the efficacy-effectiveness and safety of therapeutics In development (clinical research) In the real world (clinical care) Click to edit Master title style Patient burden is important aspect of PRO assessment in both these settings

PROMIS: Present Click to edit Master title style

FDA/C-PATH PRO Process FDA/C-Path meeting: Dec. 4, 2008

Domain development/qualification-validation lifecycle -Maturity Model- Fully test domain Industry sponsored Secondary endpoints Primary endpoints National surveys CDC NIH phase II-III studies establish MID Clinical care Click to edit Master title style Psychometrically focused testing Clinically focused testing Domain: Selection Content Expert Review Healthy People-Patient Centered: Cross Sectional Cognitive testing Focus groups Fully develop domain Items administered to representative sample and calibrated for widespread use: Web-based (large numbers) Patient groups

PROMIS Domain Framework

Items from Instrument A Items from Instrument B Items from Instrument C New Items Item Pool Probability of Response 1.0 0.8 0.6 0.4 0.2 0.0 Content Expert Review Category Response Short Form Instruments -3-2 -1 0 1 2 3 Theta Focus Groups Questionnaire administered to large representative sample Psychometric Testing Cognitive Testing Item Bank v. 1 Domain (IRT-calibrated items, reviewed for reliability-validity-sensitivity) 2.5 Information 2.0 1.5 1.0 0.5 0.0 DIF (2 0 )Analysis -3-2 -1 0 1 2 3 Theta CAT Item Information

PROMIS Wave 1 Samples Site (n=329) Demo. short form Global health General population (n=329) UNC=236 Full Bank Testing (N=7,005) Forms A-G Legacy Polimetrix (n=6,676) Stanford=93 Demo. short form Global health General population (n=6,676) Forms A-G Legacy Co-morbidity Site (n=1,203) General population (n=400) UNC=304 Stanford=96 Block Testing (N=14,128) Demo. extended form Global health Forms H-W Co-morbidity Polimetrix (n=12,925) Demo. extended form Global health Forms H-W Co-morbidity Clinical sample (n=803) General population (n=5,845) Clinical sample (n=7,080) Pittsburgh=252 Stanford=150 Duke=401

The PROMIS Validation Process Qualitative Research and Item Writing Item Testing General Population Clinical Samples Click to edit Master title style Bank Analysis Interpretation Refining

PROMIS combines: Item Response Theory (IRT) and Computer Adaptive Testing (CAT) Together, IRT and CAT provide precise measurement Click to edit of Master individual title style symptoms

Item Response Theory In psychometrics- body of theory that: Describes application of mathematical models to how people respond to items» At person and item level Serves as basis for measuring Click to edit Master title style» Abilities» Attitudes Based on probability of endorsing a particular item category is function of latent trait or ability Ability to improve reliability of instrument

Definitions Items are questions that have: Context, stems, responses Parameters (Difficulty, Discrimination) Important for analyses, calibration Banks Click to edit Master title style Collection of items that have been calibrated on a common metric difficulty and discrimination have been estimated Define common concept-domain Domains Allow computerized adaptive testing (CAT) Define latent traits/abilities

A domain is the specific feeling, function, or perception you want to measure. Examples Fatigue Pain Anxiety

A domain is the specific feeling, function, or perception you want to measure. Examples Physical function Erectile function

A domain is the specific feeling, function, or perception you want to measure. Examples Satisfaction with Social Participation General Health Perceptions

An item bank is a large collection of items measuring a single domain. Any and all items can be used to provide a score for that domain.

IRT models Latent Traits: People and Items are Represented on the Same Scale Are you able to get out of bed. Item Difficulty Are you able to run 5 miles Low Low High High Persons Levels of Physical Function 23

PROMIS Current Physical Health Banks

PROMIS Current Mental Health Banks

PROMIS Current Social Health Banks

PROMIS Adult Banks: v1.0 Items in Domains Items in Bank Short Form Emotional Distress Anger 29 8 Emotional Distress Anxiety 29 7 Emotional Distress Depression 28 8 Fatigue 95 7 Click to edit Master title style Pain Behavior 39 7 Pain interference 41 6 Physical Function 125 10 Satisfaction with Discretionary Social Activities 12 7 Satisfaction with Social Roles 14 7 Sleep Disturbance 27 8 Wake Disturbance (sleep related impairment) 16 8 Global Health 10

PROMIS II Expanded Focus on Children 4 of the 12 research sites are devoted to child-reported outcome measurement

Child-Adult Linkage Studies Render child and adult editions comparable (i.e., same scale) Result: life course outcome assessment

Pediatric PROMIS Item Banks PROMIS I 1. Physical functioning/mobility 2. Physical functioning/upper extremity 3. Pain interference 4. Fatigue 5. Depressive symptoms 6. Anxiety 7. Anger 8. Peer relationships 9. Asthma impact PROMIS II 1. Pain behavior 2. Pain quality 3. Physical activity/mobility 4. Physical activity/sedentary 5. Experiences of stress 6. Physical distress 7. Life satisfaction 8. Positive affect 9. Meaning and purpose 10. Family belonging 11. Family involvement

PROMIS Profile Short Forms (29-43-57 items) Mental Anxiety 29 Depression 28 4 6 8 Fatigue 95 Physical Pain Impact 41 Sleep Disturbance 27 Physical Function 86 Social Satisfaction with Roles 14 32 32

Value of PROMIS : Comparability Validity and Reliability Flexibility Inclusiveness Click to edit Master title style

Comparability Chemotherapy trial Osteoarthritis trial Heart failure trial

Reliability and Validity

Physical Functioning: Improved Precision vs. Legacy SF-36 10 items P re reliability = 0.90 c i s i o n Standard error HAQ 20 items 10 item CAT SE = 0.32 reliability = 0.95 SE = 0.22 SF-36 full bank Disabled rheumatoid arthritis patients normed theta values 10 item PROMIS CAT US General Population mean High physical functioning

Flexibility

Linking PROMIS and EHRs SNOMED and LOINC codes

Inclusiveness

Computerized Adaptive Testing (CAT) Integrates IRT with computers to administer a PRO instrument selects questions on the basis of a patient s response to previously administered questions Click to edit Master title style measurement is adapted to individual skips uninformative items to minimize response burden allows determination of person s standing on a domain without a loss in measurement precision.

CAT: Estimate gets more precise with every question Q1: Q2: SEM after each question Q3: Q4: Q5: -3.0-2.0-1.0 0.0 1.0 2.0 42

What is Assessment Center? Web-based research management tool Primary mechanism for distribution of PROMIS instruments Display of item- and instrument-level statistics Allows Click creation to edit Master of study-specific title style URLs for data collection Enabled to administer CATs Administration of PROMIS and other instruments FREE!!

Select CATs Click to edit Master title style

CAT Report Graph Click to edit Master title style

Effect Size: PROMIS Pain Behavior 1.6 vs. Roland-Morris 1.4 1.2 Pain Behavior (4 (4-4) items) Roland-Morris (24 items) effect size 1 0.8 0.6 0.4 0.2 0 1 2 3 time point

Mean Difference: PROMIS Pain Interference vs. BPI Interference (pain) Mean difference from baseline 8 7 6 5 4 3 2 1 0 1 2 3 time point PROMIS Pain Interference (4 (4-12) items) BPI Interference (7 items)

PROMIS Integration Options Study-specific URL in Assessment Center PROMIS and other self-reported data: email-able link to respondents Online consent and assent Standalone study or run as sub-study Downloadable modules for local installation Redcap: includes PROMIS short-forms Short-forms can be added to SurveyMonkey, epro, etc. PROsetta Stone linking measures to common PROMIS metric Electronic Health Records & Personal Health Records LOINC and SNOMED codes have been assigned to PROMIS measures

Advancing Patient-Centered Outcomes PROMIS: A Common Source of PROs Clinical Practice Click to edit Master title style Surveys (CDC) Clinical research Clinic Hospital NIH Industry FDA

Patient-Reported Outcomes: PROs PROs - Biomarkers FDA guidance: Qualification of Drug Development Tools (Oct. 2010) http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guida nces/ucm230597.pdf PROs to dissect mechanisms Knee OA Pain: AC&R July 2010 Click to edit Master title style neuropathic pain descriptors Burning, tingling, numbness, pins & needles PROs to describe disease SLE: Self-Assessed Lupus Damage Instrument AC&R: April 2010 RA: Patient-based Disease Activity Score AC&R: Feb 2008

Enhancing Pediatric Pain Pediatric Rheumatology and Rehabilitation Research Dr. Esi Morgan DeWitt-CCHMC Demonstrate validity and responsiveness in conditions that impair physical function and HRQOL Chronic pain conditions (140 children: ages 8-18) Juvenile idiopathic arthritis (120 children) Click Cerebral to palsy edit (60 children, Master 120 title parents) style Study content validity (interviews) Longitudinal study Three assessments: includes pain interference CAT and SF Develop & Test Pain Behavior and Quality Item Banks 450 children chronic: MS pain, JIA, sickle cell disease Facilitate Linking studies (Lifecycle) with adult banks

Patient-Reported Outcomes: PROs PROs measure symptoms which reflect biopsychosocial mechanisms of disease Items/questions capture symptoms Items capture mechanisms of disease PROs add to: Objective-biomarkers of disease Physician opinion regarding disease Engage patient in their care and treatment facilitate personalized care

DOMAINS vs. DISEASES Diseases (common & rare) are combinations of different mechanisms which impact domains Capturing multiple domains may be optimal way to assess diseases Core-common PRO domains are universally applicable across diseases, ages and ethnicities Core PRO domains can link common and rare diseases

A model for PROs in RA Pain Physical Function Morning stiffness Fatigue Sleep Disturbance Depression/anxiety Sexuality Satisfaction with social roles Capacity to work Family belonging Self efficacy

Rare Diseases Domain Validation-Qualification Numbers/Types of Trials? Clinically focused testing 0 Psychometrically focused testing

PROMIS Options -public private partnerships- Clinical, Translational, & CE Research Registries Population Surveillance Clinical Practice